Herbas VPB

Print
EN | LT
LT - CGRP receptoriaus antagonistai
EN - CGRP receptor antagonists

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 401/12 (2006.01)
C07D 471/04 (2006.01)
C07D 471/10 (2006.01)
C07D 471/20 (2006.01)
A61K 31/473 (2006.01)
A61K 31/4704 (2006.01)
A61K 31/517 (2006.01)
A61K 31/519 (2006.01)
A61K 31/4745 (2006.01)
A61K 31/551 (2006.01)
A61K 31/4747 (2006.01)
A61P 25/06 (2006.01)
A61P 11/06 (2006.01)
European patent
(11) Number of the document 2488512
(13) Kind of document T
(96) European patent application number 10768347.6
Date of filing the European patent application 2010-10-13
(97) Date of publication of the European application 2012-08-22
(45) Date of publication and mention of the grant of the patent 2013-11-27
(46) Date of publication of the claims translation 2014-03-25
PCT application
(86) Number PCT/US2010/052433
Date 2010-10-13
PCT application publication
(87) Number WO 2011/046997
Date 2011-04-21
Priority applications
(30) Number Date Country code
251477 P 2009-10-14 US
Inventors
(72)
LUO, Guanglin, US
DUBOWCHIK, Gene M., US
MACOR, John E., US
Grantee
(73) Bristol-Myers Squibb Company, Route 206 & Province Line Road, Princeton, NJ 08543-4000, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) CGRP receptoriaus antagonistai
  CGRP receptor antagonists
Last renewal fee
Payment date Validity (years) Amount
2025-09-16 16 347.00 EUR
Next renewal fee
2026-10-13